annb0t
Top 20
Charles River Laboratories International, Inc. CRL reported first-quarter 2024 adjusted earnings per share (EPS) of $2.27, which reflected an 18.3% decrease year over year. However, the metric surpassed the Zacks Consensus Estimate by 10.7%.
On a GAAP basis, earnings declined 35.3% year over year to $1.30 per share. The year-over-year decline in GAAP earnings was primarily due to lower revenues and gross and operating income.
Revenues
Revenues in the first quarter totaled $1.01 billion, beati...
>>> Read more: Charles River (CRL) Q1 Earnings & Revenues Beat, Fall Y/Y
On a GAAP basis, earnings declined 35.3% year over year to $1.30 per share. The year-over-year decline in GAAP earnings was primarily due to lower revenues and gross and operating income.
Revenues
Revenues in the first quarter totaled $1.01 billion, beati...
>>> Read more: Charles River (CRL) Q1 Earnings & Revenues Beat, Fall Y/Y
